GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (OTCPK:MEDXF) » Definitions » Total Operating Expense

Medexus Pharmaceuticals (Medexus Pharmaceuticals) Total Operating Expense : $48.4 Mil (TTM As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Medexus Pharmaceuticals Total Operating Expense?

Medexus Pharmaceuticals's Total Operating Expense for the three months ended in Dec. 2023 was $11.1 Mil. Medexus Pharmaceuticals's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $48.4 Mil.

Medexus Pharmaceuticals Total Operating Expense Historical Data

The historical data trend for Medexus Pharmaceuticals's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medexus Pharmaceuticals Total Operating Expense Chart

Medexus Pharmaceuticals Annual Data
Trend Dec13 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.66 32.28 41.27 50.30 51.55

Medexus Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.66 12.19 12.40 12.72 11.13

Medexus Pharmaceuticals Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $48.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medexus Pharmaceuticals Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Medexus Pharmaceuticals's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Medexus Pharmaceuticals (Medexus Pharmaceuticals) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (OTCPK:MEDXF) » Definitions » Total Operating Expense
Comparable Companies
TSX:CWEB XCNQ:HUGE TSXV:DB XCNQ:MMEN XCNQ:CXXI TSXV:ZYUS TSX:AVNT XCNQ:ACRG.A.U XCNQ:GDNS TSXV:LSL ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
P731:Germany MDP:Canada
Address
35 Nixon Road, Suite 1, Bolton, ON, CAN, L7E 1K1
Website
https://www.medexus.com
Medexus Pharmaceuticals Inc is an innovative and rare disease pharmaceutical company with a strong North American commercial platform and a portfolio of proven best-in-class products. The company's focus is on the therapeutic areas of hematology, auto-immune diseases, and allergy.